title: Reduction of monocyte 5'nucleotidase activity by gamma-interferon in multiple sclerosis and autoimmune diseases.
abstract: Ecto-5'nucleotidase (5'NT) activity in the plasma membrane of peripheral blood monocytes from patients with multiple sclerosis (MS), rheumatoid arthritis (RA), myasthenia gravis (MG), motor neuron disease (MND), and from normal control subjects of similar age was determined by radioisotopic assay. The activity in unstimulated monocytes cultured for 24 and 48 hours was found to be higher than normal in 56% of patients with active relapsing MS, 29% of patients with RA, and 7% of patients in the MG/MND group. While the enzyme activity was reduced after cultivation of the cells with recombinant interferon-gamma (gamma-IFN) in all of the groups studied, the percentage reduction was significantly greater in monocytes from patients with active relapsing MS who were in relapse at the time of sampling (p = 0.03). HLA-DR expression was monitored using immunofluorescence staining with monoclonal antibody and showed that similar numbers of monocytes in all patient and control groups expressed this antigen. Thus, while high monocyte 5'NT activity was found principally in patients with active relapsing MS and in some patients with RA, the monocytes from patients with MS were, in addition, exquisitely sensitive to stimulation with gamma-IFN.
authors.affiliation: Department of Microbiology and Immunobiology, Queen's University of Belfast, Northern Ireland.
authors.forename: M A
authors.initials: MA
authors.lastname: Armstrong
authors.forename: S
authors.initials: S
authors.lastname: Shah
authors.forename: S A
authors.initials: SA
authors.lastname: Hawkins
authors.forename: A L
authors.initials: AL
authors.lastname: Bell
authors.forename: S D
authors.initials: SD
authors.lastname: Roberts
mesh_terms: D015720:5'-Nucleotidase; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology*; D008875:Middle Aged; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology; D009046:Motor Neurons / Q000276:immunology; D009103:Multiple Sclerosis / Q000276:immunology*; D009157:Myasthenia Gravis / Q000276:immunology; D009468:Neuromuscular Diseases / Q000276:immunology; D009708:Nucleotidases / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000494:pharmacology*
chemical_list: D006684:HLA-DR Antigens; D011994:Recombinant Proteins; D007371:Interferon-gamma; D009708:Nucleotidases; D015720:5'-Nucleotidase